HealthQuill Articles by: HealthQuill
About $7 trillion in investment, or seven per cent of the global gross domestic product, flows from the public and private sectors into activities that hurt the environment, a UN report stated.
Climate Health Pharma

$7 trillion flows into economic activities that hurt nature: UNEP report

HQ Team December 11, 2023: About $7 trillion in investment, or seven per cent of the global gross domestic product, flows from the public

Read More
Australian researchers reveal that having a cat can potentially double a person’s risk of schizophrenia-related disorders transmitted through a parasite found in the animals.
Drugs Health Pharma

Exposure to a parasite found in cats may double risk of schizophrenia

HQ Team December 11, 2023: Australian researchers reveal that having a cat can potentially double a person’s risk of schizophrenia-related disorders transmitted through

Read More
African researchers and European scientists, conducting clinical trials for an HIV vaccine, have halted further vaccinations after they turned out to be ineffective in preventing people from getting the virus.
Drugs Health Pharma

African-European HIV vaccine clinical trials come to a grinding halt

HQ Team December 11, 2023: African researchers and European scientists, conducting clinical trials for an HIV vaccine, have halted further vaccinations after they turned

Read More
An “unprecedented” outbreak of anthrax, with 684 suspected human cases, has been reported from Zambia, according to the WHO.
Drugs Health Pharma

Zambia sees ‘unprecedented’ outbreak of anthrax: WHO 

HQ Team December 9, 2023: An “unprecedented” outbreak of anthrax, with 684 suspected human cases, has been reported from Zambia, according to the

Read More
Rocky Mountain spotted fever is spread to people through bites by wood ticks or dog ticks. In Brazil, it may be spread by the yellow dog tick. Image courtesy of Dr. Christopher Paddock via the Public Health Image Library of the Centers for Disease Control and Prevention.
Drugs Health Pharma

CDC issues health advisory on Rocky Mountain spotted fever, 3 die

HQ Team December 9, 2023: The Centers for Disease Control and Prevention (CDC) has issued a health advisory after three people died following

Read More
The USFDA has approved two treatments for sickle cell disease, one of them the first in the US based on gene-editing technology.
Drugs Health Pharma

US drug regulator approves two treatments for sickle cell disease 

HQ Team December 8, 2023: The USFDA has approved two treatments for sickle cell disease, one of them the first in the US

Read More
The current global risk from cholera is “very high” with vaccines running short of demand, the World Health Organization stated.
Drugs Health Pharma

WHO maintains global cholera risk at “very high” category

HQ Team December 8, 2023: The current global risk from cholera is “very high” with vaccines running short of demand, the World Health

Read More
A record number of 2,456 fuel lobbyists, tied to the world’s biggest polluting oil and gas firms and their trade groups, have been granted access to the COP28 summit in Dubai.
Climate Health Pharma

Fuel lobbyists swarm COP28, creating a ‘fog of climate denial’

HQ Team December 8, 2023: A record number of 2,456 fuel lobbyists, tied to the world’s biggest polluting oil and gas firms and

Read More
Global nations have raised $83.3 billion so far for financing climate change, according to COP28, the UN Climate Change Conference.
Climate Health Pharma

UN’s COP28 raises $83.3 billion to finance climate change

HQ Team December 7, 2023: Global nations have raised $83.3 billion so far for financing climate change, according to COP28, the UN Climate

Read More
AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to boost the North Chicago, Illinois-based company’s presence in the psychiatric and neurological disorder segment.
Drugs Health Pharma

AbbVie to acquire Cerevel for $8.7b to bolster neurological treatments

HQ Team December 7, 2023: AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to

Read More